Orphan Device Funding Authorized By Energy & Commerce: $25 Mil. Per Year
This article was originally published in The Gray Sheet
Executive Summary
The House Energy & Commerce Committee is authorizing additional funds for federal grants and contracts to develop devices and drugs for rare diseases